Taoka, K., Arai, S., Kataoka, K., Hosoi, M., Miyauchi, M., Yamazaki, S., . . . Kurokawa, M. (2018). Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate. Sci Rep.
Chicago Stili AlıntıTaoka, Kazuki, et al. "Using Patient-derived IPSCs to Develop Humanized Mouse Models for Chronic Myelomonocytic Leukemia and Therapeutic Drug Identification, Including Liposomal Clodronate." Sci Rep 2018.
MLA AlıntıTaoka, Kazuki, et al. "Using Patient-derived IPSCs to Develop Humanized Mouse Models for Chronic Myelomonocytic Leukemia and Therapeutic Drug Identification, Including Liposomal Clodronate." Sci Rep 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..